Latisse gained superstar status when it became FDA-approved to use on eyelashes for growing them longer, thicker and stronger. Over the years, there have been whispers of a whole slew of off-label use—the latest one (keep in mind it’s not FDA-approved for this) may make it a contender to rival a blepharoplasty.
New York dermatologist Deborah Sarnoff, MD, has been studying the use of Latisse to provide a chemical blepharoplasty (aka an eyelift). A study she published in the May issue of Journal of Drugs and Dermatology showed that applying the product to the upper eyelids leads to significant changes in the appearance of the area including improvement in the hooding of the upper eyelids, a deepening of the upper eyelid sulcus, less lower eyelid bulging and tightening of the skin on the lower eyelids.
You May Also Like: A Patch That De-Puffs Eyes in Just 30 Minutes
“Although there is a risk for periorbital changes that could lead to disfigurement in some patients, in properly selected candidates, when used bilaterally and the dose titrated appropriately, bimatoprost (Latisse) can have a rejuvenating effect beyond eyelash enhancement,” Dr. Sarnoff says. “The striking improvement in the periorbital appearance of some individuals using bimatoprost, is truly an eye-opening discovery that warrants further research into its potential use to achieve a ‘chemical blepharoplasty.’”
Stay tuned to NewBeauty for more updates!